Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1

Halema Khan1, Ryan C Killoran1, Anne Brickenden1

  • 1*Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada, N6A 5C1.

The Biochemical Journal
|January 14, 2015
PubMed

Insights

Kelch-like ECH-associated protein 1 (Keap1) mutations impact its ability to repress nuclear factor erythroid 2-related factor 2 (Nrf2). These structural changes in Keap1 may contribute to cancer development by altering oxidative stress responses.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Keap1 regulates the Nrf2-dependent oxidative stress response pathway.
  • Keap1 acts as a repressor of Nrf2, a transcription factor crucial for cytoprotective enzyme expression.
  • Keap1 mutations are linked to aberrant activation of the antioxidant pathway and various cancers.

Purpose of the Study:

  • To investigate the molecular effects of specific Keap1 mutations on its structure and function.
  • To understand the mechanistic links between Keap1 mutations and cancer pathogenesis.
  • To elucidate how somatic mutations affect Keap1's role as an Nrf2 repressor.

Main Methods:

  • Nuclear magnetic resonance (NMR) spectroscopy.
  • Circular dichroism (CD) spectroscopy.
  • Isothermal titration calorimetry (ITC).

Main Results:

  • Investigated mutations: G333C, G350S, G364C, G379D, R413L, R415G, A427V, G430C, and G476R.
  • Mutations showed differential effects on Keap1 protein stability and target binding, depending on their location.
  • Results provide insight into the molecular impact of somatic mutations on Keap1's Nrf2 repressor function.

Conclusions:

  • Specific Keap1 mutations alter protein stability and Nrf2 binding affinity.
  • These alterations provide mechanistic insights into Keap1's role in cancer development.
  • Understanding these molecular changes is crucial for cancer research and therapeutic strategies.

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.2K
Mismatch Repair01:36

Mismatch Repair

Overview
46.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
6.0K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
42.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.9K